In the largest study yet to assess the long-term safety and efficacy of the adjustable transobturator male system (ATOMS) to treat incontinence in men following invasive prostate treatment, the ...
UroMems, a company developing technology to treat stress urinary incontinence (SUI), received investigational device exemption (IDE) approval from FDA and French National Agency for the Safety of ...
On Wednesday, Avalon GloboCare Corp. (NASDAQ:ALBT) announced that Laboratory Services MSO, LLC has begun manufacturing the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male ...
For many men a hearty laugh or a rogue sneeze can trigger an embarrassing puddle, and too often they suffer in silence. Studies show that men wait an average of ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
LAS VEGAS -- After decades of use, the artificial urinary sphincter (AUS) finally has high-level evidence of its safety and efficacy for stress urinary incontinence (SUI) in men. What's more, patients ...
Boston Scientific has launched a docuseries campaign to remove the stigma of male incontinence. Across the videos, the campaign tells the stories of how incontinence upended the lives of three men—and ...
FREEHOLD, N.J., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative cell-based technology, cellular therapy and precision ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results